In This Section:

◄
►

Amyloidosis

See more ▼
Close X
Other videos you might like

HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi

Video

HFA 2023 Late-breaking Science Highlights

Harriette Van Spall, James L Januzzi,

Watch time: 13m 32s
HFA 23: APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis

Video

HFA 23: APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis

Marianna Fontana,

Watch time: 3m 11s
ACC 23 Expert Consensus Decision Pathway on Cardiac Amyloidosis: Highlights

Video

ACC 23 Expert Consensus Decision Pathway on Cardiac Amyloidosis

Michelle Kittleson,

Watch time: 6m 19s

Recent Videos

ESC 23: ATTRibute-CM Trial

Video

ESC 23: ATTRibute-CM Trial

Julian Gillmore,

Watch time: 4m 39s
Potential Reversibility of ATTR-CM through Anti-ATTR Amyloid Antibodies

Video

Potential Reversibility of ATTR-CM through Anti-ATTR Amyloid Antibodies

Marianna Fontana,

Watch time: 8m 1s
HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi

Video

HFA 2023 Late-breaking Science Highlights

Harriette Van Spall, James L Januzzi,

Watch time: 13m 32s
HFA 23: APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis

Video

HFA 23: APOLLO-B: Patisiran Treatment for Cardiac Amyloidosis

Marianna Fontana,

Watch time: 3m 11s
ACC 23 Expert Consensus Decision Pathway on Cardiac Amyloidosis: Highlights

Video

ACC 23 Expert Consensus Decision Pathway on Cardiac Amyloidosis

Michelle Kittleson,

Watch time: 6m 19s
AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill

Video

AHA 22 Late-Breaking Science Highlights With Dr Joseph Hill

Joseph A Hill,

Watch time: 5m 44s

Radcliffe Content

Amyloid Heart Disease

US Cardiology Review 2018;12(2):113–8.